IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Darwin Global Management, Ltd.

Q4 2022 Holdings

Filed 2023-02-14 | 4 holdings | $160.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Argenx SE(ARGX)SPONSORED ADR04016X101$112.8M297,70170.2%
Keros Therapeutics Inc(KROS)COM492327101$20.6M428,53212.8%
Ambrx Biopharma IncSPONSORED ADS02290A102$17.2M7,584,48910.7%
Prometheus Biosciences IncCOM74349U108$10.1M91,3796.3%